Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statement of Changes in Temporary Equity And Stockholders' Deficiency (Unaudited)

v3.8.0.1
Condensed Consolidated Statement of Changes in Temporary Equity And Stockholders' Deficiency (Unaudited) - 3 months ended Mar. 31, 2018 - USD ($)
Series B Convertible Redeemable Preferred Stock [Member]
Common Stock [Member]
Treasury Stock [Member]
Additional Paid-In Capital [Member]
Accumulated Other Comprehensive Loss [Member]
Accumulated Deficit [Member]
Total
Balance beginning at Dec. 31, 2017 $ 9,026,824 $ 430,674 $ (14,070) $ 80,902,967 $ (10,795,810) $ (75,544,081) $ (5,020,320)
Balance beginning, shares at Dec. 31, 2017 902,670 43,067,546 4,411        
Stock-based compensation: Common stock issued under 401(k) profit sharing plan $ 1,163 80,236 81,399
Stock-based compensation: Common stock issued under 401(k) profit sharing plan, shares 116,284        
Options and warrants 183,220 183,220
Net loss (1,425,114) (1,425,114)
Other comprehensive loss (285,609) (285,609)
Balance ending at Mar. 31, 2018 $ 9,026,824 $ 431,837 $ (14,070) $ 81,166,423 $ (11,081,419) $ (76,969,195) $ (6,466,424)
Balance ending, shares at Mar. 31, 2018 902,670 43,183,830 4,411